Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Equity Ratio (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Equity Ratio data on record, last reported at 0.52 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 388.23% year-over-year to 0.52; the TTM value through Dec 2025 reached 0.52, up 388.23%, while the annual FY2025 figure was 0.52, 388.23% up from the prior year.
  • Equity Ratio reached 0.52 in Q4 2025 per VRCA's latest filing, up from 0.42 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.94 in Q1 2023 and bottomed at 1.03 in Q3 2024.
  • Average Equity Ratio over 5 years is 0.23, with a median of 0.38 recorded in 2021.
  • The widest YoY moves for Equity Ratio: up 388.23% in 2025, down 2036.53% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.41 in 2021, then soared by 119.98% to 0.9 in 2022, then crashed by 72.94% to 0.24 in 2023, then plummeted by 175.2% to 0.18 in 2024, then skyrocketed by 388.23% to 0.52 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.52 in Q4 2025, 0.42 in Q3 2025, and 0.45 in Q2 2025.